欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/4551/001
药品名称Atosiban 37.5 mg/5 ml concentrate for solution for infusion
活性成分
    • Atosiban acetate 37.5 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Accord Healthcare B.V. Winthontlaan 200 3526 KV Utrecht Netherlands HA1 4HF UK
参考成员国 - 产品名称Netherlands (NL)
Atosiban Accord 37,5 mg/5 ml concentraat voor oplossing voor infusie
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      Atosiban 37.5 mg/5 ml concentrate for solution for infusion
    • Germany (DE)
      Atosiban Accord 37,5 mg/5ml
    • Austria (AT)
      Atosiban Accord 37,5 mg/5 ml Konzentrat zur Herstellung einer Infusionslösung
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
      Atosiban Accord
    • Norway (NO)
      Atosiban Accord
    • Poland (PL)
      Atosiban Accord
    • Lithuania (LT)
      Atosiban Accord 37,5 mg/5 ml koncentratas infuziniam tirpalui
许可日期2015/07/22
最近更新日期2025/02/05
药物ATC编码
    • G02CX01 atosiban
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase